Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial.
- 2019-01-19
- Nutrition journal 18(1)
- Guilherme Balsan
- Lúcia Campos Pellanda
- Grasiele Sausen
- Thaís Galarraga
- Denise Zaffari
- Bruna Pontin
- Vera Lúcia Portal
- Vera Lúcia Portal
- PubMed: 30660196
- DOI: 10.1186/s12937-018-0426-y
Study Design
- Type
- Randomized Controlled Trial (RCT)
- Sample size
- n = 142
- Population
- 142 men and women affected by overweight or obesity aged 35-60 years, untreated dyslipidemia and no history of coronary artery disease
- Methods
- Controlled, randomized clinical trial; participants randomized to ingest 1000 mL GT, YM or apple tea (AT, control group) daily, during eight weeks
- Blinding
- Open-label
- Duration
- eight weeks
- Funding
- Unclear
- Large Human Trial
Background
This study aimed to evaluate the effect of the intake of yerba mate (YM) and green tea (GT) on serum levels of leptin and paraoxonase-1 (PON-1), compared to control.Methods
Controlled, randomized clinical trial (RCT) that evaluated 142 men and women affected by overweight or obesity aged 35-60 years, untreated dyslipidemia and no history of coronary artery disease. Participants were randomized to ingest 1000 mL GT, YM or apple tea (AT, control group) daily, during eight weeks. Serum PON-1 and leptin levels were analyzed by ELISA immunoassay at the beginning (baseline) and after eight weeks of intervention.Results
The intake of 1 l of YM/day resulted in significant increase in serum levels of PON-1 (9.7%; p = 0.005). The consumption of GT induced no significant difference in the levels of PON-1 (p = 0.154) and leptin (p = 0.783). Intergroup analysis showed a significant difference (p = 0.036) in the variation of PON-1 levels in the YM group when compared to GT and AT groups. In addition, the increase in PON-1 levels in the YM group was significantly associated with increased HDL-c (p = 0.004).Conclusions
The intake of yerba mate increased the antioxidant capacity by increasing serum levels of PON-1 and was positively associated with increased HDL-c, stressing the protective role of this beverage against atherosclerotic diseases. GT intake had no significant effect on serum levels of PON-1 and leptin.Trial registration
This study is registered with ClinicalTrials.gov under protocol number NCT00933647.Research Insights
The consumption of GT induced no significant difference in the levels of PON-1 (p = 0.154)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 1000 mL/day
The consumption of GT induced no significant difference in the levels of PON-1 (p = 0.154)
- Effect
- Neutral
- Effect size
- Small
- Dose
- 1000 mL/day
The consumption of GT induced no significant difference in the levels of ... leptin (p = 0.783).
- Effect
- Neutral
- Effect size
- Small
- Dose
- 1000 mL/day